Zhengye Biotechnology Holding Limited Ordinary Shares Free Cash Flow Generation Index

Latest as of December 2025: 0.32x

Zhengye Biotechnology Holding Limited Ordinary Shares free cash flow generation index. Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Free Cash Flow Generation Index of 0.32x as of December 2025. Free cash flow of $13.27 Million represents 0% of operating cash flow ($41.05 Million).

FCF Generation Index

0.32x
Free Cash Flow / Operating CF

Free Cash Flow

$13.27 Million
USD

Operating Cash Flow

$41.05 Million
USD

Capital Expenditures

$27.77 Million
USD

Free Cash Flow Generation Index of Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)

Free cash flow generation index of Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025. Historical FCF Generation Index trend for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. See Zhengye Biotechnology Holding Limited Or free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Zhengye Biotechnology Holding Limited Ordinary Shares Free Cash Flow Generation Index by Year (2021–2025)

Zhengye Biotechnology Holding Limited Ordinary Shares free cash flow generation index by year from 2021 to 2025. Year-by-year Free Cash Flow Generation Index for Zhengye Biotechnology Holding Limited Ordinary Shares. For the full cash flow conversion analysis, see ZYBT operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.32x $13.27 Million $41.05 Million $27.77 Million ▲ +0.0%
2024 0.32x $13.27 Million $41.05 Million $27.77 Million ▼ -57.4%
2023 0.76x $36.58 Million $48.18 Million $11.60 Million ▲ +231.7%
2022 -0.58x $-9.99 Million $17.34 Million $27.33 Million ▼ -439.0%
2021 0.17x $5.41 Million $31.81 Million $26.40 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).